medigraphic.com
ISSN 1729-519X (Print)

2022, Number 3

<< Back Next >>

Revista Habanera de Ciencias Médicas 2022; 21 (3)

Relationship between neurological manifestations and severity of COVID-19. San Vicente de Paul Hospital. Ecuador 2021

Peñafiel GKA, Anaya GJL, Marrero FM, Rodríguez CEG

Language: Spanish
References: 21
Page: 1-7
PDF size: 765.84 Kb.


ABSTRACT

Introduction: SARS-CoV-2 mainly affects the respiratory system, but the damage caused by this virus also extends to other systems, including the nervous system, and the mechanisms of neurological infection can be direct or indirect.
Objective: To determine the relationship between neurological manifestations and disease severity in symptomatic COVID-19 positive patients at San Vicente de Paul Hospital in 2021.
Material and Methods: A cross-sectional observational study was conducted using medical records of patients hospitalized with COVID-19 and neurological manifestations, which were classified into manifestations of the central nervous system and manifestations of the peripheral nervous system.
Results: The results show that 74,1 % of patients presented neurological manifestations; the highest percentage was concentrated in patients who developed severe disease (15 [60 %], CNS; 91 [77,1 %], PNS; 125 [65,4 %], CNS and PNS). The joint presence of central and peripheral neurological manifestations was significantly associated with critical COVID-19 (P value= 0,011; OR: 2,005). The mortality rate reached 2,69 %.
Conclusions: Neurological manifestations in hospitalized COVID-19 patients are very common, and critical COVID-19 is more likely to have neurological manifestations.


REFERENCES

  1. Ministerio de Salud Pública del Ecuador. Actualización de casos de coronavirus en Ecuador [Internet]. Ecuador: Ministerio de Salud Pública del Ecuador; 2022 [Citado 26/01/2022]. Disponible en: Disponible en: https://www.salud.gob.ec/actualizacion-de-casos-de-coronavirus-en-ecuador/#:~:text 1.

  2. Vega Fernández JA, Suclupe Campos DO, Aguilar Gamboa FR. Neurological damage in SARS-CoV-2 infections. Rev la Fac Med Humana [Internet]. 2021 [Citado 26/01/2022];21(2):387-98. Disponible en: Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2308-05312021000200387&lng=es&nrm=iso#B11 2.

  3. Mariños Sánchez E, Espino Alvarado P, Rodríguez L, Barreto Acevedo E. Manifestaciones neurológicas asociadas a COVID-19 en el Hospital Edgardo Rebagliati Martins, Perú. Rev Neuropsiquiatr [Internet]. 2020 Feb 2 [Citado 01/01/2021];83(4):243-56. Disponible en: Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S0034-85972020000400243 3.

  4. Abboud H, Abboud FZ, Kharbouch H, Arkha Y, El Abbadi N, El Ouahabi A. COVID-19 and SARS-CoV-2 Infection: Pathophysiology and Clinical Effects on the Nervous System. World Neurosurg [Internet]. 2020 Aug 1 [Citado 19/11/2021];140:49-53. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/pii/S1878875020311645?via%3Dihub 4.

  5. Arriola Torres LF, Palomino Taype KR. Neurological manifestations of COVID-19: A literature review. Neurol Argentina [Internet]. 2020 Oct 1 [Citado 01/06/2021];12(4):271-4. Disponible en: Disponible en: https://www.elsevier.es/es-revista-neurologia-argentina-301-articulo-manifestaciones-neurologicas-covid-19-una-revision-S1853002820300689 5.

  6. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol [Internet]. 2020 Jun 1 [Citado 19/11/2021];77(6):683-90. Disponible en: Disponible en: https://jamanetwork.com/journals/jamaneurology/fullarticle/2764549 6.

  7. Lechien JR, Chiesa Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodríguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Oto-Rhino-Laryngology [Internet]. 2020 Aug 1 [Citado 01/06/2021];277(8):2251-61. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32253535/ 7.

  8. Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol [Internet]. 2020 Aug 1 [Citado 26/01/2022];77(8):1018-27. Disponible en: Disponible en: https://jamanetwork.com/journals/jamaneurology/fullarticle/2766766 8.

  9. Plataforma Gubernamental de Desarrollo Social. Ministro Zevallos recorrió el hospital San Vicente de Paúl y destacó trabajo articulado en Imbabura - Ministerio de Salud Pública [Internet]. Ecuador: Plataforma Gubernamental de Desarrollo Social; 2020 [Citado 02/08/2021]. Disponible en: Disponible en: https://www.salud.gob.ec/ministro-zevallos-recorrio-el-hospital-san-vicente-de-paul-y-destaco-trabajo-articulado-en-imbabura/ 9.

  10. Organización Mundial de la Salud. Manejo clínico de la COVID-19 27 de mayo de 2020 Orientaciones provisionales [Internet]. Ginebra: OMS; 2020 [Citado 19/11/2021]. Disponible en: Disponible en: https://apps.who.int/iris/bitstream/handle/10665/332638/WHO-2019-nCoV-clinical-2020.5-spa.pdf 10.

  11. Mazzanti Di Ruggiero MÁ. Declaración de Helsinki, principios y valores bioéticos en juego en la investigación médica con seres humanos. Rev Colomb Bioética [Internet]. 2011 Jan [Citado 26/01/2022];6(1):125-44. Disponible en: Disponible en: https://www.redalyc.org/pdf/1892/189219032009.pdf 11.

  12. Flores Silva FD, García Grimshaw M, Valdés Ferrer SI, Vigueras Hernández AP, Domínguez Moreno R, Tristán Samaniego DP, et al. Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City. PLoS One [Internet]. 2021 Apr 1 [Citado 02/02/2022];16(4):[Aprox. 2 p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031187/ 12.

  13. Romero Sánchez CM, Díaz Maroto I, Fernández Díaz E, Sánchez Larsen Á, Layos Romero A, García García J, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology [Internet]. 2020 Aug 25 [Citado 01/06/2021];95(8):e1060-70. Disponible en: Disponible en: https://n.neurology.org/content/95/8/e1060 13.

  14. Karadaş Ö, Öztürk B, Sonkaya AR. A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurol Sci [Internet]. 2020 Aug 1 [Citado 02/02/2022];41(8):1. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316428/ 14.

  15. Luigetti M, Iorio R, Bentivoglio AR, Tricoli L, Riso V, Marotta J, et al. Assessment of neurological manifestations in hospitalized patients with COVID-19. Eur J Neurol [Internet]. 2020 Nov 1 [Citado 02/02/2022];27(11):2322-8. Disponible en: Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/ene.14444 15.

  16. Abdullahi A, Candan SA, Abba MA, Bello AH, Alshehri MA, Afamefuna Victor E, et al. Neurological and musculoskeletal features of COVID-19: A systematic review and meta-analysis. Front Neurol [Internet]. 2020 [Citado 02/02/2022];11:687. Disponible en: Disponible en: https://www.frontiersin.org/articles/10.3389/fneur.2020.00687/full 16.

  17. Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis [Internet]. 2020 Jul 28 [Citado 02/02/2022];71(15):769-77. Disponible en: Disponible en: https://academic.oup.com/cid/article/71/15/769/5807944 17.

  18. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 NovelCoronavirus-Infected Pneumonia in Wuhan, China. JAMA [Internet]. 2020 Mar 17 [Citado 02/02/2022];323(11):1061. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042881/ 18.

  19. Wong CKH, Wong JYH, Tang EHM, Au CH, Wai AKC. Clinical presentations, laboratory and radiological findings, and treatments for 11,028 COVID-19 patients: a systematic review and meta-analysis. Sci Reports [Internet]. 2020 Nov 13 [Citado 02/02/2022];10(1):1-16. Disponible en: Disponible en: https://www.nature.com/articles/s41598-020-74988-9 19.

  20. Pinzon RT, Wijaya VO, Buana RB, Al Jody A, Nunsio PN. Neurologic characteristics in coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Front Neurol [Internet]. 2020 [Citado 02/02/2022];11:565. Disponible en: Disponible en: https://www.frontiersin.org/articles/10.3389/fneur.2020.00565/full 20.

  21. Misra S, Kolappa K, Prasad M, Radhakrishnan D, Thakur KT, Solomon T, et al. Frequency of Neurologic Manifestations in COVID-19. Neurology [Internet]. 2021 Dec 7 [Citado 29/01/2022];97(23):e2269-81. Disponible en: Disponible en: https://n.neurology.org/content/97/23/e2269 21.




2020     |     www.medigraphic.com